A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
A Prospective, Interventional, Multicenter, Phase IV, Open-label, Single Arm Study to Assess the Safety and Effectiveness of Finerenone in Participants From India With Chronic Kidney Disease Associated With Type 2 Diabetes.
Sponsor: Bayer
This PHASE4 trial investigates Chronic Kidney Disease and Type 2 Diabetes Mellitus and is currently completed. Bayer leads this study, which shows 28 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
28 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Aug 2025 — Sep 2025 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jul 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE4
-
Jun 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE4
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE4
▶ Show 23 earlier versions
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE4
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE4
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE4
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting PHASE4
-
Dec 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE4
-
Nov 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE4
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE4
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE4
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
May 2024 — Jun 2024 [monthly]
Recruiting PHASE4
-
Mar 2024 — May 2024 [monthly]
Recruiting PHASE4
-
Feb 2024 — Mar 2024 [monthly]
Recruiting PHASE4
-
Jan 2024 — Feb 2024 [monthly]
Recruiting PHASE4
-
Dec 2023 — Jan 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Dec 2023 [monthly]
Recruiting PHASE4
-
Sep 2023 — Oct 2023 [monthly]
Recruiting PHASE4
-
Aug 2023 — Sep 2023 [monthly]
Recruiting PHASE4
-
Jul 2023 — Aug 2023 [monthly]
Recruiting PHASE4
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE4
-
Apr 2023 — Jun 2023 [monthly]
Recruiting PHASE4
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2023 — Mar 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bangalore, India , Bhubaneswar, India , Chennai, India , Chowk Lucknow, India , Faridabad, India , Gorimedu, India , Hyderabad, India , Karnataka, India , Kolkata, India , Lucknow, India and 5 more locations